The present paper discusses the current literature with regard to substance-assisted
psychotherapy with Methylenedioxymethamphetamine (MDMA) for posttraumatic stress …

This article discusses current literature on the use of 3, 4‐methylenedioxymethamphetamine
(MDMA)‐assisted psychotherapy in the treatment of posttraumatic stress disorder (PTSD) …

Background Posttraumatic stress disorder (PTSD) is a common psychiatric condition that
can develop following a traumatic experience. PTSD is associated with significant disability …

Posttraumatic stress disorder (PTSD) treatment guidelines have unequivocally designated
psychotherapy as a first-line treatment, despite well-documented neurobiological alterations …

Background: Posttraumatic stress disorder often does not resolve after conventional
psychotherapies or pharmacotherapies. Pilot studies have reported that 3, 4 …

Case reports indicate that psychiatrists administered±3, 4-
methylenedioxymethamphetamine (MDMA) as a catalyst to psychotherapy before …

Psychiatrists and psychotherapists in the US (1970s to 1985) and Switzerland (1988–1993)
used MDMA legally as a prescription drug, to enhance the effectiveness of psychotherapy …

Abstract Background: 3, 4-methylenedioxymethamphetamine (MDMA), known recreationally
as “Molly” or “Ecstasy”, is a triple monoamine reuptake inhibitor. MDMA specifically acts as a …

Rationale Posttraumatic stress disorder (PTSD) is a chronic condition that has wide-ranging
negative effects on an individual's health and interpersonal relationships. Treatments with …

Since the wars in Iraq and Afghanistan, posttraumatic stress disorder (PTSD) has become a
major area of research and development. The most widely accepted treatment for PTSD is …